DTIL

PRECISION BIOSCIENCES INC

Biological Products, (No Diagnostic Substances)NasdaqNon-accelerated filer<br>Smaller reporting company

Total Trades

92

Buys

19

Sells

36

Largest Trade

N/A

Insiders

10

Institutional Funds

47

Inst. Value

$1M+

Activist Filings

37

Insider Trades

InsiderTitleTypeValueSharesPriceDate
SMITH J. JEFFERSONChief Research Off…GRANT$1K–$15K1K$12.42May 3, 2024
List AlanChief Medical Offi…SELL$1K–$15K290$10.32May 3, 2024
List AlanChief Medical Offi…EXERCISEN/A982May 3, 2024
Amoroso MichaelPresident and CEOSELL$15K–$50K2K$10.32May 3, 2024
Amoroso MichaelPresident and CEOEXERCISEN/A3KMay 3, 2024
List AlanChief Medical Offi…SELL$1K–$15K238$10.03Apr 30, 2024
List AlanChief Medical Offi…EXERCISEN/A868Apr 30, 2024
Amoroso MichaelPresident and CEOSELL$15K–$50K137K$0.36Jan 24, 2024
Amoroso MichaelPresident and CEOEXERCISEN/A267KJan 24, 2024
Scimeca DarioGeneral Counsel an…SELL$1K–$15K21K$0.36Jan 24, 2024
Scimeca DarioGeneral Counsel an…EXERCISEN/A59KJan 24, 2024
List AlanChief Medical Offi…SELL$1K–$15K22K$0.36Jan 24, 2024
List AlanChief Medical Offi…EXERCISEN/A60KJan 24, 2024
SMITH J. JEFFERSONChief Research Off…EXERCISEN/A75KJan 24, 2024
SMITH J. JEFFERSONChief Research Off…SELL$1K–$15K28K$0.37Jan 24, 2024
Scimeca DarioGeneral Counsel an…SELL$1K–$15K16K$0.40Nov 6, 2023
Scimeca DarioGeneral Counsel an…EXERCISEN/A55KNov 6, 2023
Amoroso MichaelPresident and CEOEXERCISEN/A283KNov 6, 2023
Amoroso MichaelPresident and CEOSELL$50K–$100K125K$0.40Nov 6, 2023
Scimeca DarioGeneral Counsel an…SELL$1K–$15K13K$0.75Jun 9, 2023
Scimeca DarioGeneral Counsel an…EXERCISEN/A32KJun 9, 2023
List AlanChief Medical Offi…EXERCISEN/A26KApr 28, 2023
List AlanChief Medical Offi…SELL$1K–$15K8K$0.79Apr 28, 2023
Amoroso MichaelPresident and CEOEXERCISEN/A103KMar 23, 2023
Amoroso MichaelPresident and CEOSELL$15K–$50K47K$0.82Mar 23, 2023
Kelly John AlexanderCFOBUY$15K–$50K20K$0.86Mar 21, 2023
Scimeca DarioGeneral Counsel an…SELL$1K–$15K12K$1.07Mar 7, 2023
Scimeca DarioGeneral Counsel an…EXERCISEN/A28KMar 7, 2023
Scimeca DarioGeneral Counsel an…GRANT$1K–$15K2K$0.95Mar 7, 2023
List AlanChief Medical Offi…EXERCISEN/A29KMar 7, 2023
List AlanChief Medical Offi…SELL$1K–$15K9K$1.07Mar 7, 2023
Amoroso MichaelPresident and CEOEXERCISEN/A24KOct 18, 2022
Amoroso MichaelPresident and CEOSELL$1K–$15K11K$1.32Oct 18, 2022
Kelly John AlexanderCFOBUY$50K–$100K45K$1.32Sep 26, 2022
Kelly John AlexanderCFOBUY$50K–$100K34K$1.50Jun 24, 2022
JANTZ DEREKChief Scientific O…SELL$15K–$50K19K$2.06Jun 9, 2022
JANTZ DEREKChief Scientific O…EXERCISEN/A42KJun 9, 2022
Scimeca DarioGeneral Counsel an…SELL$15K–$50K10K$2.06Jun 9, 2022
Scimeca DarioGeneral Counsel an…EXERCISEN/A32KJun 9, 2022
List AlanChief Medical Offi…EXERCISEN/A26KApr 28, 2022
List AlanChief Medical Offi…SELL$15K–$50K8K$2.10Apr 28, 2022
Kelly John AlexanderCFOBUY$50K–$100K17K$3.08Mar 21, 2022
🔓Seeing ranges? Sign in for exact trade values — free forever

Institutional Ownership

13F filings as of Dec 31, 2025 · 47 funds holding

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

TANG CAPITAL MANAGEMENT, LLC

SC 13G/A · Feb 17, 2026

0.0%

0 shares

Lynx1 Capital Management LP

SC 13G/A · Feb 17, 2026

4.1%

994K shares

Bleichroeder LP

SC 13G/A · Feb 13, 2026

8.2%

1.9M shares

Octagon Capital Advisors LP

SC 13G · Feb 10, 2026

10.0%

2.3M shares

Aberdeen Group plc

SC 13G · Jan 27, 2026

8.9%

2.1M shares

Empery Asset Management, LP

SC 13G · Jan 22, 2026

10.0%

2.3M shares

LYNX1 CAPITAL MANAGEMENT LP

SC 13G/A · Nov 14, 2025

8.8%

1.0M shares

Readout Capital, LP

SC 13G/A · Aug 14, 2025

9.3%

1.1M shares

Bleichroeder LP

SC 13G · Aug 14, 2025

9.7%

1.1M shares

Aquilo Capital, L.P.

SC 13G/A · Aug 6, 2025

0.0%

0 shares

Novartis Pharma AG

SC 13G/A · Aug 6, 2025

3.7%

414K shares

TANG CAPITAL MANAGEMENT, LLC

SC 13G/A · May 15, 2025

6.4%

673K shares

Highbridge Capital Management, LLC

SC 13G/A · Apr 25, 2025

3.7%

406K shares

Readout Capital, LP

SC 13G · Mar 26, 2025

8.8%

920K shares

Weinstein Benjamin

SC 13G · Mar 18, 2025

5.2%

395K shares

Aquilo Capital, L.P.

SC 13G/A · Feb 14, 2025

6.6%

521K shares

JANUS HENDERSON GROUP PLC

SC 13G/A · Feb 14, 2025

0.0%

0 shares

Lynx1 Capital Management LP

SC 13G · Feb 14, 2025

10.0%

766K shares

Novartis Pharma AG

SC 13G/A · Feb 12, 2025

5.4%

414K shares

Perceptive Advisors LLC

SC 13G/A · Nov 14, 2024

5.9%

426K shares

Tang Capital Management, LLC

SC 13G/A · Nov 14, 2024

8.6%

623K shares

9.7%

702K shares

5.3%

406K shares

Aquilo Capital, L.P.

SC 13G · Mar 18, 2024

7.1%

467K shares

Perceptive Advisors LLC

SC 13G · Mar 14, 2024

7.9%

500K shares

8.0%

511K shares

Great Point Partners, LLC

SC 13G/A · Feb 14, 2024

0.0%

0 shares

Capital World Investors 95-1411037

SC 13G/A · Feb 12, 2024

4.2%

5.1M shares

Great Point Partners, LLC

SC 13G · Feb 27, 2023

7.3%

8.1M shares

Great Point Partners, LLC

SC 13G/A · Feb 14, 2023

3.4%

3.8M shares

Capital World Investors 95-1411037

SC 13G/A · Feb 13, 2023

6.1%

6.7M shares

Eli Lilly and Company 35-0470950

SC 13G/A · Jan 27, 2023

3.4%

3.8M shares

Derek Jantz

SC 13G/A · Aug 31, 2022

3.9%

4.3M shares

BlackRock, Inc.

SC 13G · Jul 8, 2022

2.4%

2.4M shares

Great Point Partners, LLC

SC 13G · Jul 1, 2022

5.9%

5.8M shares

Novartis Pharma AG

SC 13G · Jun 27, 2022

16.6%

12.4M shares

Capital World Investors 95-1411037

SC 13G/A · Feb 11, 2022

7.0%

4.3M shares

View on Google Finance →